Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

about

Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.The use of pharmacogenetic testing in patients with schizophrenia or bipolar disorder: A systematic review

P2860

Q47628101-27EE2AE9-EE27-419D-A47A-16CD47E2CB6C Q58567910-3AFB543F-AEB0-4538-958D-3D8618D89819

P2860

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

Item

http://www.wikidata.org/entity/Q40562486

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

@en

type

Item

label

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

@en

prefLabel

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

@en

P1476

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

@en

P2093

Kamini Vasudev

http://www.w3.org/2001/XMLSchema#string

Richard B Kim

http://www.w3.org/2001/XMLSchema#string

Ross Norman

http://www.w3.org/2001/XMLSchema#string

Ute I Schwarz

http://www.w3.org/2001/XMLSchema#string

Yun-Hee Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.

The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Obesity hypertension: role of leptin and sympathetic nervous system.

P304

138-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0706743716670128

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27681143

http://www.w3.org/2001/XMLSchema#string

P932

5298525

http://www.w3.org/2001/XMLSchema#string

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

about

P2860

P2860

Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932